Furthermore, Shen et al. [48] found that TIMELESS was down-regulated in cellular senescence, and deletion of clock protein TIMELESS may promote the cellular senescence and exacerbate genome instability at the onset of senescence, suggesting that TIMELESS inhibitors have potential applications in cancer prevention. The gene discussed is TIMELESS; the disease is cancer.